- Release Date: 21/01/25 09:57
- Summary: Patient Dosing Complete in Phase II ABSSSI Trial of R327G
- Price Sensitive: Yes
- Download Document 286.92KB
- Forums
- ASX - By Stock
- RCE
- Ann: Patient Dosing Complete in Phase II ABSSSI Trial of R327G
RCE
recce pharmaceuticals ltd
Add to My Watchlist
5.62%
!
42.0¢

Ann: Patient Dosing Complete in Phase II ABSSSI Trial of R327G
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M |
Open | High | Low | Value | Volume |
44.0¢ | 44.0¢ | 41.5¢ | $45.92K | 107.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 120 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 120 | 0.420 |
1 | 17172 | 0.415 |
1 | 19894 | 0.400 |
2 | 11696 | 0.390 |
2 | 107000 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 1000 | 1 |
0.435 | 10819 | 1 |
0.440 | 8669 | 2 |
0.450 | 20976 | 3 |
0.460 | 24304 | 3 |
Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |